Shares of Surgery Partners, Inc. (NASDAQ:SGRY – Get Free Report) have been given an average rating of “Hold” by the twelve analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $20.70.
Several brokerages have weighed in on SGRY. UBS Group cut Surgery Partners from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $21.00 to $23.50 in a research note on Wednesday, October 28th. Benchmark reiterated a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. Mizuho lowered Surgery Partners from an “outperform” rating to a “neutral” rating and increased their price target for the company from $19.00 to $25.00 in a report on Wednesday, November 11th. Raymond James Financial set a $23.50 price target on Surgery Partners in a research report on Monday, October 26th. Finally, Stonex Financial lowered shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th.
Check Out Our Latest Analysis on SGRY
Institutional Trading of Surgery Partners
Institutional investors have recently added to or reduced their stakes in the company. BROOKFIELD Corp ON purchased a new position in shares of Surgery Partners during the third quarter worth approximately $22,370,000. Zacks Investment Management raised its stake in shares of Surgery Partners by 198.5% during the third quarter. Zacks Investment Management now owns 191,570 shares of the company’s stock valued at $2,657,000 after acquiring an additional 127,389 shares in the last quarter. Algert Global LLC purchased a new stake in shares of Surgery Partners in the third quarter valued at approximately $646,000. Allworth Financial LP boosted its holdings in shares of Surgery Partners by 239.3% in the third quarter. Allworth Financial LP now owns 2,677 shares of the company’s stock valued at $37,000 after purchasing an additional 1,888 shares during the period. Finally, Jump Financial LLC purchased a new stake in shares of Surgery Partners in the third quarter valued at approximately $1,470,000.
Surgery Partners Price Performance
Shares of NASDAQ:SGRY opened at $26.69 on Friday. The company has a quick ratio of 2.01, a current ratio of 2.17 and a debt-to-equity ratio of 1.03. The stock has a market capitalization of $3.49 billion, a PE ratio of -39.25 and a beta of 1.85. The firm’s 50 day moving average price is $18.31 and its 200-day moving average price is $15.34. Surgery Partners has a twelve month low of $11.41 and a twelve month high of $27.23.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its earnings results on Monday, November 9th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Surgery Partners had a positive return on equity of 0.98% and a negative net margin of 2.59%. The company had revenue of $815.30 million for the quarter, compared to analysts’ expectations of $820.96 million. During the same period last year, the firm earned $0.13 EPS. Surgery Partners’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts expect that Surgery Partners will post 0.14 EPS for the current year.
About Surgery Partners
Surgery Partners, Inc. is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties. The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States. Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.
Featured Articles
- Five stocks we like better than Surgery Partners
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
